Miao QF - Search Results

1

An EGFR-targeting antibody-drug conjugate LR004-VC-MMAE: potential in esophageal squamous cell carcinoma and other malignancies.

Hu XY, Wang R, Jin J, Liu XJ, Cui AL, Sun LQ, Li YP, Li Y, Wang YC, Zhen YS, Miao QF, Li ZR. Hu XY, et al. Among authors: miao qf. Mol Oncol. 2019 Feb;13(2):246-263. doi: 10.1002/1878-0261.12400. Epub 2018 Nov 15. Mol Oncol. 2019. PMID: 30372581 Free PMC article.

2

An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activity.

Miao QF, Liu XY, Shang BY, Ouyang ZG, Zhen YS. Miao QF, et al. Anticancer Drugs. 2007 Feb;18(2):127-37. doi: 10.1097/CAD.0b013e3280112779. Anticancer Drugs. 2007. PMID: 17159599

3

Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin.

Miao Q, Shang B, Ouyang Z, Liu X, Zhen Y. Miao Q, et al. Sci China C Life Sci. 2007 Aug;50(4):447-56. doi: 10.1007/s11427-007-0058-5. Sci China C Life Sci. 2007. PMID: 17653664

4

[Construction of energized fusion protein consisting of epidermal growth factor receptor oligopeptide ligand and lidamycin and its antitumor activity].

Guo XF, Zhong GS, Miao QF, Zhen YS. Guo XF, et al. Among authors: miao qf. Ai Zheng. 2009 Jun;28(6):561-8. Ai Zheng. 2009. PMID: 19635191 Free article. Chinese.

5

[Anti-type IV collagenase single-chain antibody ameliorates bleomycin-induced experimental pulmonary fibrosis in mice].

Lai RY, Miao QF, Li Y, Zhen YS. Lai RY, et al. Among authors: miao qf. Zhonghua Yi Xue Za Zhi. 2009 May 26;89(20):1411-5. Zhonghua Yi Xue Za Zhi. 2009. PMID: 19671337 Chinese.

6

Binding capability of the enediyne-associated apoprotein to human tumors and constitution of a ligand oligopeptide-integrated protein.

Cai L, Chen H, Miao Q, Wu S, Shang Y, Zhen Y. Cai L, et al. J Biotechnol. 2009 Oct 26;144(2):142-50. doi: 10.1016/j.jbiotec.2009.09.001. Epub 2009 Sep 6. J Biotechnol. 2009. PMID: 19737585

7

[Construction and screening of phage antibody libraries against epidermal growth factor receptor and soluble expression of single chain Fv].

Sheng WJ, Miao QF, Zhen YS. Sheng WJ, et al. Among authors: miao qf. Yao Xue Xue Bao. 2009 Jun;44(6):597-602. Yao Xue Xue Bao. 2009. PMID: 19806889 Chinese.

8

A tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic mice.

Zhong G, Zhang S, Li Y, Liu X, Gao R, Miao Q, Zhen Y. Zhong G, et al. Cancer Lett. 2010 Sep 1;295(1):124-33. doi: 10.1016/j.canlet.2010.02.020. Epub 2010 Mar 19. Cancer Lett. 2010. PMID: 20303650

9

Antitumor effects of an engineered and energized fusion protein consisting of an anti-CD20 scFv fragment and lidamycin.

Fang H, Miao Q, Zhang S, Cheng X, Xiong D, Zhen Y. Fang H, et al. Sci China Life Sci. 2011 Mar;54(3):255-62. doi: 10.1007/s11427-011-4143-4. Epub 2011 Mar 16. Sci China Life Sci. 2011. PMID: 21416325 Free article.

10

Antitumor efficacy of the scFv-based fusion protein and its enediyne-energized analogue directed against epidermal growth factor receptor.

Sheng W, Shang Y, Miao Q, Li Y, Zhen Y. Sheng W, et al. Anticancer Drugs. 2012 Apr;23(4):406-16. doi: 10.1097/CAD.0b013e32834f9801. Anticancer Drugs. 2012. PMID: 22205154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters